Robert Maki MD PhD – MSK Sarcoma Oncologist & Early Drug Development Specialist is a surgical oncologist based in New York, New York. Located in the 10022 postal area, this practice specializes in the surgical treatment of sarcoma, a complex form of cancer that arises in connective tissues. The focus on surgical oncology means that patients receive expert care centered on the removal and management of tumors through advanced surgical techniques, tailored to individual patient needs.
Situated at 160 E 53rd St, the practice serves a diverse population in New York City, offering specialized surgical oncology services with a strong emphasis on sarcoma cases. The facility integrates surgical expertise with ongoing developments in early drug research, supporting innovative approaches to cancer treatment. This combination enables the surgical oncologist to participate in multidisciplinary care, often collaborating with other specialists to optimize patient outcomes.
The practice is distinguished by its involvement in early drug development, which reflects a commitment to advancing new therapeutic options for sarcoma patients. By combining clinical care with research, this surgical oncologist helps bridge the gap between emerging cancer treatments and practical application. Patients benefit from access to cutting-edge therapies and clinical trials that may not be widely available elsewhere.
Robert Maki MD PhD – MSK Sarcoma Oncologist & Early Drug Development Specialist provides comprehensive surgical oncology services with a focus on sarcoma management in New York, New York. The practice emphasizes precision in surgical intervention and ongoing innovation in cancer treatment, ensuring patients receive care informed by the latest advancements in the field. For consultation or appointments, the office can be reached by phone at 347-929-7619.
